Results 41 to 50 of about 187 (83)
Defibrillation Threshold in Patients with Chronic Chagas' Heart Disease: Are There Benefits or not Worth the Risk? [PDF]
Teixeira RA.
europepmc +1 more source
La forma clínica más común de la enfermedad de Chagas en Colombia es la cardiomiopatía chagásica crónica. Sin embargo, recientemente se han presentado nueve brotes de Chagas agudo (EChA) de probable transmisión oral en áreas de baja endemia con escasa ...
Martha L. Díaz, Clara I. González
doaj
Noninvasive Cardiac Radioablation for Chagas Heart Disease. [PDF]
Wiener PC +4 more
europepmc +1 more source
Os efeitos da terapia de ressincronizaçao cardíaca (TRC) em pacientes com cardiomiopatia isquêmica (CMI) e dilatada (CMD) sao bem conhecidos. Entretanto, faltam evidências científicas da TRC na cardiomiopatia chagásica crônica (CCC). OBJETIVO: avaliar o
Martino Martinelli Filho +7 more
doaj +2 more sources
Evaluation of Various Pathophysiological Pathways in the Prognosis of Heart Failure with Reduced Ejection Fraction: Seeing Beyond the Heart. [PDF]
Barbosa-Ferreira JM, Oliveira AA.
europepmc +1 more source
FUNDAMENTO: Os pacientes com insuficiência cardíaca (IC) que são internados apresentando má perfusão e congestão (perfil clínico-hemodinâmico C) constituem o grupo que evolui com pior prognóstico na IC descompensada.
Juliano Cardoso +8 more
doaj
T1 Mapping in Heart Failure: Prognostic Implications. [PDF]
Moharem-Elgamal S.
europepmc +1 more source
Diagnostic and Prognostic Importance of Functional Capacity in the Different Evolutionary Forms of Chagas Disease. [PDF]
Barbosa-Ferreira JM +2 more
europepmc +1 more source
16-Year Evolution of Acute Orally Transmitted Chagas Disease: Report of an Autochthonous Case Progressing to Chagasic Cardiomyopathy. [PDF]
Silva MRHSE +6 more
europepmc +1 more source
Does Galectin-3 (Myocardial Fibrosis Biomarker) Predict Progression in Chagas Disease? [PDF]
Pedrosa RC.
europepmc +1 more source

